(Q39776599)

https://api.crossref.org/works/10.1212/WNL.26.8.777

14 September 2017

Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease (English)

1 reference

6 May 2022

0 references

V. S. Achar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A133299

6 May 2022

K. M. Welch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A133299

6 May 2022

E. Chabi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A133299

6 May 2022

K. Bartosh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A133299

6 May 2022

J. S. Meyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A133299

6 May 2022

language of work or name

English

0 references

publication date

1 August 1976

1 reference

full work available at URL

14 September 2017

http://journals.lww.com/00006114-197608000-00011

1 reference

https://api.crossref.org/works/10.1212/WNL.26.8.777

6 May 2022

1 reference

14 September 2017

26

1 reference

14 September 2017

8

1 reference

14 September 2017

777-780

1 reference

14 September 2017

Identifiers

DOI

10.1212/WNL.26.8.777

1 reference

14 September 2017

1 reference